Tatva Chintan Pharma Chem Limited

NSEI:TATVA Voorraadrapport

Marktkapitalisatie: ₹20.0b

Tatva Chintan Pharma Chem Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Tatva Chintan Pharma Chem has a total shareholder equity of ₹7.4B and total debt of ₹152.3M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₹8.1B and ₹694.2M respectively. Tatva Chintan Pharma Chem's EBIT is ₹197.1M making its interest coverage ratio -11.6. It has cash and short-term investments of ₹148.7M.

Belangrijke informatie

2.1%

Verhouding schuld/eigen vermogen

₹152.31m

Schuld

Rente dekkingsratio-11.6x
Contant₹148.73m
Aandelen₹7.38b
Totaal verplichtingen₹694.18m
Totaal activa₹8.07b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Analyse van de financiële positie

Kortlopende schulden: TATVA's short term assets (₹2.5B) exceed its short term liabilities (₹678.2M).

Langlopende schulden: TATVA's short term assets (₹2.5B) exceed its long term liabilities (₹15.9M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: TATVA's net debt to equity ratio (0.05%) is considered satisfactory.

Schuld verminderen: TATVA's debt to equity ratio has reduced from 85% to 2.1% over the past 5 years.

Schuldendekking: TATVA's debt is well covered by operating cash flow (259.2%).

Rentedekking: TATVA earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven